[1]
Donadio, M. 2018. Lapatinib and capecitabine as third-line therapy in young woman with advanced breast cancer: Lapatinib e capecitabina in III linea in donna giovane affetta da carcinoma mammario avanzato. AboutOpen. 4, 1 (Jun. 2018), 35–38. DOI:https://doi.org/10.19156/abtpn.2018.0037.